Skip to main content
Erschienen in: PharmacoEconomics 6/2003

01.04.2003 | Original Research Article

A Pharmacy-Based Health Promotion Programme in Hypertension

Cost-Benefit Analysis

verfasst von: Isabelle Côté, Jean-Pierre Grégoire, Dr Jocelyne Moisan, Isabelle Chabot, Guy Lacroix

Erschienen in: PharmacoEconomics | Ausgabe 6/2003

Einloggen, um Zugang zu erhalten

Abstract

Objective: To weigh the costs and benefits of a pharmacy-based health promotion programme implemented in four pharmacies of the Quebec City area, Canada. This programme was developed to improve blood pressure control through activities aimed at improving the quality of prescribing and the adherence to treatment.
Design: Nine pharmacies in Quebec City were included, of which four pharmacies were assigned to the implementation of the health promotion programme. Each time a study participant came to one of these pharmacies to refill his/her antihypertensive medication, the pharmacist would measure and record the participant’s blood pressure and assess adherence to drug treatment. The other five pharmacies delivered usual care. The duration of the intervention programme was 9 months. Costs included direct, indirect, and fixed costs, and the costs of pharmacist intervention. Benefits were measured using cost savings induced by pharmacist intervention. Willingness to pay was also considered. A bootstrap method was used to test the between-group difference.
Perspective: The study was performed from a societal perspective.
Study participants: 100 individuals aged between 34 and 80 years residing in the Quebec City area and taking antihypertensive medication.
Main outcome measures and results: Participants exposed to the programme had a significant decrease in mean direct costs and a significant increase in mean indirect costs compared with non-exposed participants. Pharmacist interventions involved a mean cost of 30.68 Canadian dollars ($Can) per participant exposed to the programme. On average, exposed participants were willing to pay $Can0.54 per month after the intervention period. Benefits were about ten times higher than costs (1998 values).
Conclusions: The implementation of this intervention programme seems promising in the quest to improve blood pressure control in terms of both costs and benefits.
Literatur
1.
Zurück zum Zitat Joffres MR, Ghadirian P, Fodor JG, et al. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10 (10 Pt 1): 1097–102PubMedCrossRef Joffres MR, Ghadirian P, Fodor JG, et al. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10 (10 Pt 1): 1097–102PubMedCrossRef
2.
Zurück zum Zitat Chockalingam A, Fodor JG. Treatment of raised blood pressure in the population: the Canadian experience. Am J Hypertens 1998; 11 (6 Pt 1): 747–9PubMedCrossRef Chockalingam A, Fodor JG. Treatment of raised blood pressure in the population: the Canadian experience. Am J Hypertens 1998; 11 (6 Pt 1): 747–9PubMedCrossRef
3.
Zurück zum Zitat MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335 (8692): 765–74PubMedCrossRef MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335 (8692): 765–74PubMedCrossRef
4.
Zurück zum Zitat Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997; 277 (9): 739–45PubMedCrossRef Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997; 277 (9): 739–45PubMedCrossRef
5.
Zurück zum Zitat Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. NIH publication no. 98-4080. Bethesda (MD): National Institute of Health, 1997 Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. NIH publication no. 98-4080. Bethesda (MD): National Institute of Health, 1997
6.
Zurück zum Zitat Grégoire J-P, Guibert R, Archambault A, et al. Measurement of non-compliance to antihypertensive medication using pill counts and pharmacy records. J Soc Adm Pharm 1997; 14 (4): 198–207 Grégoire J-P, Guibert R, Archambault A, et al. Measurement of non-compliance to antihypertensive medication using pill counts and pharmacy records. J Soc Adm Pharm 1997; 14 (4): 198–207
7.
Zurück zum Zitat McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973; 48: 1104–11PubMedCrossRef McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973; 48: 1104–11PubMedCrossRef
8.
Zurück zum Zitat Hammarlund ER, Ostrom JR, Kethley AJ. The effects of drug counseling and other educational strategies on drug utilization of the elderly. Med Care 1985; 23: 165–70PubMedCrossRef Hammarlund ER, Ostrom JR, Kethley AJ. The effects of drug counseling and other educational strategies on drug utilization of the elderly. Med Care 1985; 23: 165–70PubMedCrossRef
9.
Zurück zum Zitat Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997; 17 (1): 140–7PubMed Erickson SR, Slaughter R, Halapy H. Pharmacists’ ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997; 17 (1): 140–7PubMed
10.
Zurück zum Zitat Chabot I. Impact d’un programme d’intervention sur la tension artérielle d’hypertendus traités pharmacologiquement en pharmacie communautaire. Une étude exploratoire [PhD thesis]. Québec: Université Laval, 2001 Chabot I. Impact d’un programme d’intervention sur la tension artérielle d’hypertendus traités pharmacologiquement en pharmacie communautaire. Une étude exploratoire [PhD thesis]. Québec: Université Laval, 2001
11.
Zurück zum Zitat Chabot I, Moisan J, Gregoire JP, et al. Effect of a pharmacybased intervention program on blood pressure [abstract]. Pharmacoepidemiol Drug Saf 2000; 9: S122 Chabot I, Moisan J, Gregoire JP, et al. Effect of a pharmacybased intervention program on blood pressure [abstract]. Pharmacoepidemiol Drug Saf 2000; 9: S122
12.
Zurück zum Zitat Green LW, Kreuter MW. Health promotion planning: an educational and environmental approach. 2nd ed. Mountain View (CA): Mayfield Publishing Company, 1991 Green LW, Kreuter MW. Health promotion planning: an educational and environmental approach. 2nd ed. Mountain View (CA): Mayfield Publishing Company, 1991
13.
Zurück zum Zitat Santé Québec. Et la santé, ça va en 1992–1993? Rapport de l’enquête sociale et de santé 1992–1993: vol 1. Québec: Gouvemement du Québec, 1995 Santé Québec. Et la santé, ça va en 1992–1993? Rapport de l’enquête sociale et de santé 1992–1993: vol 1. Québec: Gouvemement du Québec, 1995
14.
Zurück zum Zitat Fortin B, Garneau G, Lacroix G, et al. L’économie souterraine an Québec: mythes et réalités. Québec: Presses de l’ Université Laval, 1996 Fortin B, Garneau G, Lacroix G, et al. L’économie souterraine an Québec: mythes et réalités. Québec: Presses de l’ Université Laval, 1996
15.
Zurück zum Zitat World Health Organization. Manual of the international classification of diseases, injuries and causes of death. 8th rev. ed. Geneva: World Health Organization, 1967 World Health Organization. Manual of the international classification of diseases, injuries and causes of death. 8th rev. ed. Geneva: World Health Organization, 1967
16.
Zurück zum Zitat Rethans JJ, Sturmans F, Drop R, et al. Does competence of general practitioners predict their performance: comparison between examination setting and actual practice. BMJ 1991; 303 (6814): 1377–80CrossRef Rethans JJ, Sturmans F, Drop R, et al. Does competence of general practitioners predict their performance: comparison between examination setting and actual practice. BMJ 1991; 303 (6814): 1377–80CrossRef
17.
Zurück zum Zitat Rethans JJ, Saebu L. Do general practitioners act consistently in real practice when they meet the same patient twice? Examination of intradoctor variation using standardised (simulated) patients. BMJ 1997; 314 (7088): 1170–3PubMedCrossRef Rethans JJ, Saebu L. Do general practitioners act consistently in real practice when they meet the same patient twice? Examination of intradoctor variation using standardised (simulated) patients. BMJ 1997; 314 (7088): 1170–3PubMedCrossRef
18.
Zurück zum Zitat Desgagné A, Castilloux AM, Angers IF, et al. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998; 13 (5): 487–97PubMedCrossRef Desgagné A, Castilloux AM, Angers IF, et al. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998; 13 (5): 487–97PubMedCrossRef
19.
Zurück zum Zitat Drummond M, O’Brien B, Stoddart G, et al. Methods for the economics evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997 Drummond M, O’Brien B, Stoddart G, et al. Methods for the economics evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
20.
Zurück zum Zitat Santé Québec, Lavallée C, Belleronse C, et al. Aspects sociaux reliés à la santé. Rapport de l’enquête sociale et de santé 1992–1993, vol. 2. Montréal: ministère de la Santé et des Services sociaux, Gouvernement du Québec, 1995 Santé Québec, Lavallée C, Belleronse C, et al. Aspects sociaux reliés à la santé. Rapport de l’enquête sociale et de santé 1992–1993, vol. 2. Montréal: ministère de la Santé et des Services sociaux, Gouvernement du Québec, 1995
21.
Zurück zum Zitat Munroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19 (1): 113–23PubMedCrossRef Munroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997; 19 (1): 113–23PubMedCrossRef
22.
Zurück zum Zitat Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995; 41 (5): 469–72PubMed Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995; 41 (5): 469–72PubMed
23.
Zurück zum Zitat Bozek PS, Perdue BE, Bar-Din M, et al. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health Syst Pharm 1998; 55 (11): 1151–5PubMed Bozek PS, Perdue BE, Bar-Din M, et al. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health Syst Pharm 1998; 55 (11): 1151–5PubMed
24.
Zurück zum Zitat Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998; 18 (5): 1103–11PubMed Galt KA. Cost avoidance, acceptance, and outcomes associated with a pharmacotherapy consult clinic in a Veterans Affairs Medical Center. Pharmacotherapy 1998; 18 (5): 1103–11PubMed
25.
Zurück zum Zitat Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Québec pharmacists’ behavior. Ann Pharmacother 2000; 34 (3): 309–16PubMedCrossRef Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Québec pharmacists’ behavior. Ann Pharmacother 2000; 34 (3): 309–16PubMedCrossRef
26.
Zurück zum Zitat Cook T, Campbell D. Quasi-experimentation: design and analysis issues for fields settings. Boston (MA): Houghton Mifflin Company, 1979 Cook T, Campbell D. Quasi-experimentation: design and analysis issues for fields settings. Boston (MA): Houghton Mifflin Company, 1979
27.
Zurück zum Zitat Rossi P, Freeman H. Evaluation. 5th ed. Newbury Park (CA): Sage Publications Inc, 1993 Rossi P, Freeman H. Evaluation. 5th ed. Newbury Park (CA): Sage Publications Inc, 1993
28.
Zurück zum Zitat Santé Québec, Daveluy C, Chenard L, et al. Et votre coeur, ça va? Rapport de l’Enquête québécoise sur la santé cardiovasculaire 1990. Montréal: Ministere de la Santé et des Services sociaux, gouvernement du Québec, 1994 Santé Québec, Daveluy C, Chenard L, et al. Et votre coeur, ça va? Rapport de l’Enquête québécoise sur la santé cardiovasculaire 1990. Montréal: Ministere de la Santé et des Services sociaux, gouvernement du Québec, 1994
29.
Zurück zum Zitat Baltussen R, Leidl R, Ament A. The impact of age on cost-effectiveness ratios and its control in decision making. Health Econ 1996; 5 (3): 227–39PubMedCrossRef Baltussen R, Leidl R, Ament A. The impact of age on cost-effectiveness ratios and its control in decision making. Health Econ 1996; 5 (3): 227–39PubMedCrossRef
Metadaten
Titel
A Pharmacy-Based Health Promotion Programme in Hypertension
Cost-Benefit Analysis
verfasst von
Isabelle Côté
Jean-Pierre Grégoire
Dr Jocelyne Moisan
Isabelle Chabot
Guy Lacroix
Publikationsdatum
01.04.2003
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 6/2003
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321060-00005

Weitere Artikel der Ausgabe 6/2003

PharmacoEconomics 6/2003 Zur Ausgabe